Site-specific generation of Herceptin radioimmunoconjugates and their in vivo evaluation by PET
A chemoenzymatic approach has been successfully employed to generate various 89Zr-labelled Herceptin conjugates with a high level of purity. The utility of these constructs in an in vivo context was assessed by PET.
Date:
20 May 2016, 13:30 (Friday, 4th week, Trinity 2016)
Venue:
Old Road Campus Research Building, Headington OX3 7DQ
Venue Details:
71a, b & c, Department of Oncology
Speaker:
Dr Cristina Marculescu (University of Oxford)
Organising department:
Department of Oncology
Organisers:
Dr Michael Youdell (University of Oxford),
Anne-Marie Honeyman-Tafa (University of Oxford)
Organiser contact email address:
anne-marie.honeyman-tafa@oncology.ox.ac.uk
Hosts:
Dr Bart Cornelissen (University of Oxford),
Professor Katherine Vallis (University )
Part of:
CRUK & EPSRC Cancer Imaging Centre in Oxford
Booking required?:
Not required
Audience:
Public
Editor:
Anne-Marie Honeyman-Tafa
